109 related articles for article (PubMed ID: 15812853)
1. A novel homogenous assay for topoisomerase II action and inhibition.
Jahnz M; Medina MA; Schwille P
Chembiochem; 2005 May; 6(5):920-6. PubMed ID: 15812853
[TBL] [Abstract][Full Text] [Related]
2. Use of catalytic topoisomerase II inhibitors to probe mechanisms of chemical-induced clastogenicity in Chinese hamster V79 cells.
Snyder RD
Environ Mol Mutagen; 2000; 35(1):13-21. PubMed ID: 10692223
[TBL] [Abstract][Full Text] [Related]
3. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
[TBL] [Abstract][Full Text] [Related]
4. Topoisomerase II poisoning and antineoplastic action by DNA-nonbinding diacetyl and dicarboxaldoxime derivatives of ferrocene.
Vashisht Gopal YN; Jayaraju D; Kondapi AK
Arch Biochem Biophys; 2000 Apr; 376(1):229-35. PubMed ID: 10729210
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of a series of fluoroquinoanthroxazines with contrasting dual mechanisms of action against topoisomerase II and G-quadruplexes.
Kim MY; Duan W; Gleason-Guzman M; Hurley LH
J Med Chem; 2003 Feb; 46(4):571-83. PubMed ID: 12570378
[TBL] [Abstract][Full Text] [Related]
6. Anthocyanidins modulate the activity of human DNA topoisomerases I and II and affect cellular DNA integrity.
Habermeyer M; Fritz J; Barthelmes HU; Christensen MO; Larsen MK; Boege F; Marko D
Chem Res Toxicol; 2005 Sep; 18(9):1395-404. PubMed ID: 16167831
[TBL] [Abstract][Full Text] [Related]
7. An atypical type II topoisomerase from Mycobacterium smegmatis with positive supercoiling activity.
Jain P; Nagaraja V
Mol Microbiol; 2005 Dec; 58(5):1392-405. PubMed ID: 16313624
[TBL] [Abstract][Full Text] [Related]
8. [The role of topoisomerase II in mammalian cells response to ionizing radiation. II. Effect of a small concentration of novobiocin on cell cycle in x-rays irradiated HeLa cells].
Kirrilova TV
Tsitologiia; 2000; 42(2):176-80. PubMed ID: 10752123
[TBL] [Abstract][Full Text] [Related]
9. Quantitative adaptation of the bacteriophage P4 DNA unknotting assay for use in the biochemical and pharmacological characterization of topoisomerase II.
Hofmann GA; Mirabelli CK; Drake FH
Anticancer Drug Des; 1990 Aug; 5(3):273-82. PubMed ID: 2169250
[TBL] [Abstract][Full Text] [Related]
10. [Role of topoisomerase II in the response of mammalian cells to the action of ionizing radiation. I. Change in the mitotic cell cycle of Chinese hamster CHO K1, irradiated with x-rays, after the action of novobiocin at a high concentration].
Kirillova TV; Spivak IM
Tsitologiia; 1999; 41(1):53-9. PubMed ID: 10380286
[TBL] [Abstract][Full Text] [Related]
11. The cardio-protecting agent and topoisomerase II catalytic inhibitor sobuzoxane enhances doxorubicin-DNA adduct mediated cytotoxicity.
Swift LP; Cutts SM; Nudelman A; Levovich I; Rephaeli A; Phillips DR
Cancer Chemother Pharmacol; 2008 Apr; 61(5):739-49. PubMed ID: 17594094
[TBL] [Abstract][Full Text] [Related]
12. Critical structural motif for the catalytic inhibition of human topoisomerase II by UK-1 and analogs.
Wang BB; Maghami N; Goodlin VL; Smith PJ
Bioorg Med Chem Lett; 2004 Jun; 14(12):3221-6. PubMed ID: 15149679
[TBL] [Abstract][Full Text] [Related]
13. Synergistic interaction between histone deacetylase and topoisomerase II inhibitors is mediated through topoisomerase IIbeta.
Marchion DC; Bicaku E; Turner JG; Daud AI; Sullivan DM; Munster PN
Clin Cancer Res; 2005 Dec; 11(23):8467-75. PubMed ID: 16322310
[TBL] [Abstract][Full Text] [Related]
14. Substituted purine analogues define a novel structural class of catalytic topoisomerase II inhibitors.
Jensen LH; Thougaard AV; Grauslund M; Søkilde B; Carstensen EV; Dvinge HK; Scudiero DA; Jensen PB; Shoemaker RH; Sehested M
Cancer Res; 2005 Aug; 65(16):7470-7. PubMed ID: 16103101
[TBL] [Abstract][Full Text] [Related]
15. Thanatop: a novel 5-nitrofuran that is a highly active, cell-permeable inhibitor of topoisomerase II.
Polycarpou-Schwarz M; Müller K; Denger S; Riddell A; Lewis J; Gannon F; Reid G
Cancer Res; 2007 May; 67(9):4451-8. PubMed ID: 17483360
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a new class of catalytic topoisomerase II inhibitors targeting the ATP-binding site by structure based design. Part I.
Furet P; Schoepfer J; Radimerski T; Chène P
Bioorg Med Chem Lett; 2009 Aug; 19(15):4014-7. PubMed ID: 19560355
[TBL] [Abstract][Full Text] [Related]
17. In vitro assessment of novel transcription inhibitors and topoisomerase poisons in rhabdomyosarcoma cell lines.
Wolf SJ; Wakelin LP; He Z; Stewart BW; Catchpoole DR
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1059-69. PubMed ID: 19277661
[TBL] [Abstract][Full Text] [Related]
18. NK314, a novel topoisomerase II inhibitor, induces rapid DNA double-strand breaks and exhibits superior antitumor effects against tumors resistant to other topoisomerase II inhibitors.
Onda T; Toyoda E; Miyazaki O; Seno C; Kagaya S; Okamoto K; Nishikawa K
Cancer Lett; 2008 Jan; 259(1):99-110. PubMed ID: 17998154
[TBL] [Abstract][Full Text] [Related]
19. Endoreduplication induced in cultured Chinese hamster cells by different anti-topoisomerase II chemicals. Evidence for the essential contribution of the enzyme to chromosome segregation.
Pastor N; Cantero G; Campanella C; Cortés F
Mutat Res; 2005 Apr; 582(1-2):11-9. PubMed ID: 15781205
[TBL] [Abstract][Full Text] [Related]
20. Partial purification of mitochondrial DNA topoisomerase II from Plasmodium falciparum and its sensitivity to inhibitors.
Chavalitshewinkoon-Petmitr P; Worasing R; Wilairat P
Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):733-8. PubMed ID: 12041546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
